EVO Evotec SE American Depositary Shares Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
07:38
Oct 06
psyduckcapital
EVO should catch up on plague story
Expects EVO to catch up with NVAX, MRNA and EBS, which popped on the pneumonic plague story, because EVO is literally developing a clinical pneumonic plague antibody with the US DoD.
EVO Evotec SE American Depositary Shares Long — —
07:30
Oct 06
psyduckcapital
EVO the clear plague play
Asked for plays on the plague news, he names EVO as the clear play because it has a clinical pneumonic plague project with the US DoD.
EVO Evotec SE American Depositary Shares Long 1ST — —
22:45
Feb 26
Kyle Grieve We Study Billionaires
We Study Billionaires
Kyle explicitly states, "I've discussed businesses like Evolution Gaming... I no longer own it." While not detailing the specific exit reason in this clip, the mention serves as an example of "belief updating"—changing one's mind when the thesis breaks, regardless of past identity as a holder. AVOID (Confirmed exit). N/A (Position closed).
EVO Evotec SE American Depositary Shares Avoid — —
Log in to see ideas

About EVO Investor Commentary

Across the available history and selected sources, Buzzberg tracks EVO (Evotec SE American Depositary Shares) across 5 sources: 3 bullish vs 0 bearish calls from 5 authors. Historical directional balance: 7% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 45 total trade ideas tracked. Latest voices: psyduckcapital, Kyle Grieve.